Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14962006 | 0.89 | CYP2D6 (0.32) | LMNACYP2D6GPR84 | |
| SCHEMBL14962003 | 0.88 | — | — | |
| SCHEMBL14962009 | 0.88 | SIGMAR1 (0.30) | SIGMAR1 | |
| SCHEMBL14962002 | 0.85 | SIGMAR1 (0.36) | SIGMAR1ACHE | |
| SCHEMBL14962005 | 0.78 | ADORA3 (0.36) | SIGMAR1 | |
| SCHEMBL14962010 | 0.76 | — | — | |
| SCHEMBL14961999 | 0.76 | ALDH1A1 (0.34) | ACHE | |
| SCHEMBL14962015 | 0.76 | — | — | |
| SCHEMBL8204842 | 0.74 | SIGMAR1 (0.44) | SIGMAR1CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL12700269 | 0.72 | SIGMAR1 (0.40) | SIGMAR1NR1I2LMNAADRA2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11563178-B2 | Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element | UDC IRELAND LIMITED (IE) | 2023-01-24 | — | — | US | disclosed |
| US-20180069179-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | UDC IRELAND LTD (IE) | 2018-03-08 | — | — | US | disclosed |
| US-20180069179-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | UDC IRELAND LTD (IE) | 2018-03-08 | — | — | US | disclosed |
| US-20130126835-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | UDC IRELAND LIMITED (IE) | 2013-05-23 | — | — | US | disclosed |
| US-20130126835-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | UDC IRELAND LIMITED (IE) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180069179-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | L1CAM, RER1, H1-0 | SIGMAR1 1001/4885NR1I2 557/4885LMNA 3527/4885 |
| US-11563178-B2 | Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element | L1CAM, RER1, H1-0 | SIGMAR1 1001/4885NR1I2 557/4885LMNA 3527/4885 |
| US-20130126835-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | L1CAM, RER1, H1-0 | SIGMAR1 1001/4885NR1I2 557/4885LMNA 3527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.